Company: Halpern & Slater LLC
Location: Stow, Massachusetts, United States
John H. Halpern, MD, Physician at Halpern & Slater LLC, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in the health care industry.
Utilizing 25 years of practiced experience in psychiatry, Dr. Halpern has been serving in a private practice, Halpern & Slater LLC, since 2018. Prior to this role, he was a medical director at the Recovery Centers of America at Danvers from 2016 to 2018, director of the Laboratory for Integrative Psychiatry at Harvard Medical School from 2008 to 2016, and assistant professor of psychiatry at Harvard Medical School from 2006 to 2016. In addition to these roles, he served as the associate director of substance abuse research in the Biological Psychiatry Laboratory at the Alcohol and Drug Research Center of McLean Hospital from 2003 to 2009, where he previously acted as a research fellow in the Biological Psychiatry Laboratory and Clinical Neuroendocrinology Laboratory beginning in 1997.
A diplomate of the American Board of Psychiatry and Neurology, Dr. Halpern holds a Bachelor of Arts in biological sciences from the University of Chicago and a Doctor of Medicine from the State University of New York at Brooklyn. He completed an internship at Carney Hospital in Boston, MA, in 1994, followed by a psychiatric residency at the Harvard Longwood Psychiatry Residency Training Program from 1994 to 1998. Alongside his primary career endeavors, he was the chief medical officer of Entheogen Corporation, and he has been serving as a consultant to the Gerson Leyman Group since 2002.
In light of his myriad accomplishments, Dr. Halpern was named a fellow of the Boston Medical Library and received multiple accolades, including the National Research Service Award and the Young Investigator Award from the American Psychiatric Association. He has also been a frequent grantee of the Multidisciplinary Association for Psychedelic Studies, the National Institute on Drug Abuse, and the Heffter Research Institute. Likewise, he is a Peter Livingston Fellow of Harvard Medical School, an Ethel DuPont-Warren Fellow, and a Laughlin Fellow of the American College of Psychiatrists. However, he is most renowned for his patent on the drug 2-Bromo-LSD, an important treatment for cluster headaches. Impressively, he has also been featured in the first edition of Who’s Who of Emerging Leaders in America, the 60th edition of Who’s Who in America, and the ninth and 10th editions of Who’s Who in Science and Engineering.
For more information, please visit:
Contact Dr. Halpern: